Ryan J Coller,Kristina Singh-Verdeflor,Jens Eickhoff et al. Ryan J Coller et al.

The primary clinical outcome was the severe respiratory illness (SRI) event rate, defined as hospitalizations due to respiratory diagnoses. Clinicaltrials.gov registration is NCT05292365.

Jia Ee Chia,Song Peng Ang,Jose Iglesias et al. Jia Ee Chia et al.

Methods: We conducted a retrospective cohort study using the National Inpatient Sample (2016-2021) to analyze AIS hospitalizations among patients with and without SLE.

Wesley R White,Jessica L Coker,Clare C Brown Wesley R White

Results: Data from 6 445 496 delivery hospitalizations were used.

Julio Nunez,Anna Mollar,Mayra Vera-Aviles et al. Julio Nunez et al.

Intravenous (IV) iron therapy improves symptoms and reduces hospitalizations for HF. Several mechanisms have been proposed, including myocardial iron repletion. However, it is unknown if serum iron markers predict the extent of this repletion.

Qionghua Xiao,Yuanming Huang,Bingyu Xue et al. Qionghua Xiao et al.

In terms of efficacy evaluation, biologics were associated with a 45% reduction in AER (RR: 0.55; P < 0.0001), a 57% reduction of asthma-related hospitalizations (RR: 0.43; P < 0.0001), an increase in the forced expiratory volume in 1 s (FEV1) of 0.13 L (P < 0.0001), a reduction in asthma control questionnaire

Pavitraa Saravana Kumar,Yogapriya Chidambaram,G Shree Devi et al. Pavitraa Saravana Kumar et al.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors, initially developed for diabetes management, have demonstrated cardiovascular benefits, including reductions in HF hospitalizations and mortality.

Matthew Christopher Ryan,Marcel Jose Yibirin Wakim,Sebastian Suarez Matthew Christopher Ryan

Case presentation: This report highlights a 28-year-old male with Crohn's disease (CD) with recurrent hospitalizations of abdominal pain, hematuria, nausea, vomiting, and diarrhea.

María Victoria Santos Guzmán,Daimi Rivera,Isabella Marian Reyna Guerrero et al. María Victoria Santos Guzmán et al.

In EMPEROR-Preserved (n = 5,792; median follow-up 26.2 months), empagliflozin reduced heart failure hospitalizations from 11.1% to 8.3% and cardiovascular mortality from 16.2% to 13.4% (hazard ratio (HR) 0.75; 95% confidence interval (CI) 0.68-0.84)....In a multi-agent trial (n = 1,253; 18 months), SGLT2 inhibitors lowered cardiovascular mortality (4% vs. 5%) and HF hospitalizations (7% vs. 10%), with an absolute risk reduction of 1% and 3%, respectively, and improved patient-reported quality of life (mean Kansas City Cardiomyopathy Questionnaire (

Ana Luiza Bierrenbach,Cintia Irene Parellada,Tulio Tadeu Rocha Sarmento et al. Ana Luiza Bierrenbach et al.

This descriptive ecological study evaluated the program's impact on hospitalizations for AGW and high-grade-CIN using interrupted time series analysis of data from the Brazilian Hospital Information System from 2011 to 2019....From 2011 to 2019, there were 4,312 AGW hospitalizations among females, 7,295 AGW hospitalizations among males, and 84,306 hospitalizations for high-grade CIN....Following the implementation of the HPV vaccination program, significant reductions in hospitalizations for AGW and high-grade CIN were observed, particularly in the targeted 15-19-year-old age group....In this group, the median number of hospitalizations prevented was 174 (95% CI: 154-193) for AGW among females, 116 (95% CI: 86-147) for AGW among males, and 217 (95% CI: 94-339) for high-grade CIN, with strong model fits....The HPV vaccination program has significantly reduced hospitalizations for AGW and high-grade CIN in Brazil, particularly among the targeted age group.

Margarita Ramos,Margaret Rush,Yuliya Oumarbaeva-Malone et al. Margarita Ramos et al.

Results: In total, 66 560 hospitalizations were included; 82.4% occurred at hospitals with at least 1 CMC-dedicated care model.